{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T03:29:55Z","timestamp":1790566195410,"version":"4.1.0"},"reference-count":82,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2009,1,23]],"date-time":"2009-01-23T00:00:00Z","timestamp":1232668800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Familial Cancer"],"published-print":{"date-parts":[[2009,9]]},"DOI":"10.1007\/s10689-009-9233-0","type":"journal-article","created":{"date-parts":[[2009,1,22]],"date-time":"2009-01-22T05:44:47Z","timestamp":1232603087000},"page":"231-239","source":"Crossref","is-referenced-by-count":50,"title":["Lymphocyte recruitment into the tumor site is altered in patients with MSI-H colon cancer"],"prefix":"10.1007","volume":"8","author":[{"given":"Kristen M.","family":"Drescher","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Poonam","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrice","family":"Watson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zoran","family":"Gatalica","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen N.","family":"Thibodeau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry T.","family":"Lynch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,1,23]]},"reference":[{"key":"9233_CR1","doi-asserted-by":"crossref","first-page":"8","DOI":"10.3322\/canjclin.54.1.8","volume":"54","author":"A Jemal","year":"2004","unstructured":"Jemal A, Thomas A, Murray T, Thun M (2004) Cancer statistics. CA Cancer J Clin 54:8\u201329","journal-title":"CA Cancer J Clin"},{"key":"9233_CR2","first-page":"801","volume":"25","author":"HT Lynch","year":"1999","unstructured":"Lynch HT, de la Chapelle A (1999) Genetic susceptibility to nonpolyposis colorectal cancer. J Med Genet 25:801\u2013818","journal-title":"J Med Genet"},{"key":"9233_CR3","volume-title":"The genetic basis of human cancer","author":"B Vogelstein","year":"1998","unstructured":"Vogelstein B, Kinzler KW (1998) The genetic basis of human cancer. McGraw Hill, New York"},{"key":"9233_CR4","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1056\/NEJMra012242","volume":"348","author":"HT Lynch","year":"2003","unstructured":"Lynch HT, de la Chapelle A (2003) Hereditary colorectal cancer. N Eng J Med 348:919\u2013932","journal-title":"N Eng J Med"},{"key":"9233_CR5","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1126\/science.8484122","volume":"260","author":"SN Thibodeau","year":"1993","unstructured":"Thibodeau SN, Bren G, Schaid D (1993) Microsatellite instability in cancer of the proximal colon. Science 260:816\u2013819","journal-title":"Science"},{"key":"9233_CR6","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1126\/science.8484121","volume":"260","author":"LA Aaltonen","year":"1993","unstructured":"Aaltonen LA, Peltom\u00e4ki P, Leach FS et al (1993) Clues to the pathogenesis of familial colorectal cancer. Science 260:812\u2013816","journal-title":"Science"},{"key":"9233_CR7","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1038\/363558a0","volume":"363","author":"Y Ionov","year":"1993","unstructured":"Ionov Y, Peinado MA, Malkhosyan S et al (1993) Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesis. Nature 363:558\u2013561","journal-title":"Nature"},{"key":"9233_CR8","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1046\/j.1365-2168.2000.01508.x","volume":"87","author":"CM Wright","year":"2000","unstructured":"Wright CM, Dent OF, Barker M (2000) The prognostic significance of extensive microsatellite instability in sporadic clinicopathological stage C colorectal cancer. Br J Surgery 87:1197\u20131202","journal-title":"Br J Surgery"},{"key":"9233_CR9","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1056\/NEJM200001133420201","volume":"342","author":"R Gryfe","year":"2000","unstructured":"Gryfe R, Kim H, Hsieh ET et al (2000) Tumor microsatellite instability and clinical outcome in young patients with colorectal cancer. N Eng J Med 342:69\u201377","journal-title":"N Eng J Med"},{"key":"9233_CR10","first-page":"917","volume":"10","author":"WS Samowitz","year":"2001","unstructured":"Samowitz WS, Curtin K, Ma K-N et al (2001) Microsatellite instability in sporadic colon cancer is associated with an improved prognosis at the population level. Can Epidemiol Biomark Prev 10:917\u2013923","journal-title":"Can Epidemiol Biomark Prev"},{"key":"9233_CR11","first-page":"5849","volume":"53","author":"RA Lothe","year":"1993","unstructured":"Lothe RA, Peltomaki P, Meling GI (1993) Genomic instability in colorectal cancer: relationship to clinicopathological variables and family history. Cancer Res 53:5849\u20135852","journal-title":"Cancer Res"},{"key":"9233_CR12","doi-asserted-by":"crossref","first-page":"e26","DOI":"10.1097\/00006676-200401000-00023","volume":"28","author":"A Fukunaga","year":"2004","unstructured":"Fukunaga A, Miyamoto M, Cho Y et al (2004) CD8+ tumor-infiltrating lymphocytes together with CD4+ tumor-infiltrating lymphocytes and dendritic cells improve the prognosis of patients with pancreatic adenocarcinoma. Pancreas 28:e26\u2013e31","journal-title":"Pancreas"},{"key":"9233_CR13","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1002\/path.996","volume":"196","author":"E Yakirevich","year":"2002","unstructured":"Yakirevich E, Lefel O, Sova Y et al (2002) Activated status of tumour-infiltrating lymphocytes and apoptosis in testicular seminoma. J Pathol 196:67\u201375","journal-title":"J Pathol"},{"key":"9233_CR14","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1002\/(SICI)1096-9896(199707)182:3<318::AID-PATH862>3.0.CO;2-6","volume":"182","author":"KM Ropponen","year":"1997","unstructured":"Ropponen KM, Eskelinen MJ, Lipponen PK et al (1997) Prognostic value of tumour-infiltrating lymphocytes (TILs) in colorectal cancer. J Pathol 182:318\u2013324","journal-title":"J Pathol"},{"key":"9233_CR15","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s005350050269","volume":"34","author":"J Kitayama","year":"1999","unstructured":"Kitayama J, Nagawa H, Nakayama H et al (1999) Functional expression of \u03b21 and \u03b22 integrins on tumor infiltrating lymphocytes (TILs) in colorectal cancer. J Gastroent 34:327\u2013333","journal-title":"J Gastroent"},{"key":"9233_CR16","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1007\/s005350170031","volume":"36","author":"Y Fukuzawa","year":"2001","unstructured":"Fukuzawa Y, Takahashi K, Furuta K et al (2001) Expression of Fas\/Fas ligand (FasL) and its involvement in infiltrating lymphocytes in hepatocellular carcinoma. J Gastroent 36:681\u2013688","journal-title":"J Gastroent"},{"key":"9233_CR17","first-page":"3560","volume":"6","author":"K Okada","year":"2000","unstructured":"Okada K, Komuta K, Hashimoto S et al (2000) Frequency of apoptosis of tumor-infiltrating lymphocytes induced by fas counterattack in human colorectal carcinoma and its correlation with prognosis. Clinical Cancer Research 6:3560\u20133564","journal-title":"Clinical Cancer Research"},{"key":"9233_CR18","doi-asserted-by":"crossref","first-page":"5669","DOI":"10.4049\/jimmunol.160.11.5669","volume":"160","author":"MW Bennett","year":"1998","unstructured":"Bennett MW, O\u2019Connell J, O\u2019Sullivan GC et al (1998) The fas counterattack in vivo: apoptotic depletion of tumor-infiltrating lymphocytes associated with fas ligand expression by human esophageal carcinoma. J Immunol 160:5669\u20135675","journal-title":"J Immunol"},{"key":"9233_CR19","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/S0002-9440(10)63994-6","volume":"158","author":"J Alexander","year":"2001","unstructured":"Alexander J, Wantanabe T, Wu TT et al (2001) Histopathological identification of colon cancer with microsatellite instability. Am J Pathol 158:527\u2013535","journal-title":"Am J Pathol"},{"key":"9233_CR20","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1002\/1097-0142(20010615)91:12<2417::AID-CNCR1276>3.0.CO;2-U","volume":"91","author":"TC Smyrk","year":"2001","unstructured":"Smyrk TC, Watson P, Kaul K, Lynch HL (2001) Tumor infiltrating lymphocytes are a marker for microsatellite instability in colorectal cancer. Cancer 91:2417\u20132422","journal-title":"Cancer"},{"key":"9233_CR21","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.ejso.2003.10.001","volume":"30","author":"M Ikeguchi","year":"2004","unstructured":"Ikeguchi M, Oi K, Hirooka Y, Kaibara N (2004) CD8+ lymphocyte infiltration and apoptosis in hepatocellular carcinoma. EJSO 30:53\u201357","journal-title":"EJSO"},{"key":"9233_CR22","first-page":"361","volume":"3","author":"SM Lippman","year":"1990","unstructured":"Lippman SM, Spier CM, Miller TP et al (1990) Tumor-infiltrating T-lymphocytes in B-cell diffuse large cell lymphoma related to disease course. Mod Pathol 3:361\u2013367","journal-title":"Mod Pathol"},{"key":"9233_CR23","doi-asserted-by":"crossref","first-page":"5211","DOI":"10.4049\/jimmunol.163.10.5211","volume":"163","author":"J Shimizu","year":"1999","unstructured":"Shimizu J, Yamazaki S, Sakaguchi S (1999) Induction of tumor immunity by removing CD25+ CD4+ T cells: a common basis between tumor immunity and autoimmunity. J Immunol 163:5211\u20135218","journal-title":"J Immunol"},{"key":"9233_CR24","first-page":"4435","volume":"25","author":"V Karja","year":"2005","unstructured":"Karja V, Aaltomaa S, Lipponen P et al (2005) Tumor-infiltrating lymphocytes: a prognostic factor of PSA-free survival in patients with local prostate carcinoma treated by radical prostatectomy. Antican Res 25:4435\u20134438","journal-title":"Antican Res"},{"key":"9233_CR25","first-page":"233","volume":"7","author":"S Tsujitani","year":"1993","unstructured":"Tsujitani S, Kakeji Y, Maehara Y et al (1993) Dendritic cells prevent lymph node metastasis in patients in gastric cancer. In Vivo 7:233\u2013237","journal-title":"In Vivo"},{"key":"9233_CR26","first-page":"3137","volume":"8","author":"TE Reichert","year":"2002","unstructured":"Reichert TE, Strauss L, Wagner EM et al (2002) Signaling abnormalities, apoptosis, and reduced proliferation of circulating and tumor-infiltrating lymphocytes in patients with oral carcinoma. Clin Can Res 8:3137\u20133145","journal-title":"Clin Can Res"},{"key":"9233_CR27","first-page":"41","volume":"26","author":"M Ohta","year":"2005","unstructured":"Ohta M, Tanaka F, Yamaguchi H et al (2005) The high expression of fractalkine results in a better prognosis for colorectal cancer patients. Int J Oncol 26:41\u201347","journal-title":"Int J Oncol"},{"key":"9233_CR28","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1442-2050.2007.00655.x","volume":"20","author":"SJ Guo","year":"2007","unstructured":"Guo SJ, Lin DM, Li J et al (2007) Tumor-associated macrophages and CD3-zeta expression of tumor-infiltrating lymphocytes in human esophageal squamous-cell carcinoma. Dis Esophagus 20:107\u2013116","journal-title":"Dis Esophagus"},{"key":"9233_CR29","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1002\/cncr.10346","volume":"94","author":"S Ishigama","year":"2002","unstructured":"Ishigama S, Natsugoe S, Tokuda K et al (2002) CD3-\u03b6 chain expression of intratumoral lymphocytes is closely related to survival in gastric carcinoma patients. Cancer 94:1437\u20131442","journal-title":"Cancer"},{"key":"9233_CR30","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1038\/sj.bjc.6601240","volume":"89","author":"A Houston","year":"2003","unstructured":"Houston A, Bennett MW, O\u2019Sullivan GC et al (2003) Fas ligand mediates immune privilege and not inflammation in human colon cancer, irrespective of TGF-\u03b2 expression. Br J Can 89:1345\u20131351","journal-title":"Br J Can"},{"key":"9233_CR31","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1002\/bjs.4472","volume":"91","author":"SM Phillips","year":"2004","unstructured":"Phillips SM, Banerjea A, Feakins R et al (2004) Tumour-infiltrating lymphocytes in colorectal cancer with microsatellite instability are activated and cytotoxic. Br J Surgery 91:469\u2013475","journal-title":"Br J Surgery"},{"key":"9233_CR32","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1136\/gut.44.2.156","volume":"44","author":"MW Bennett","year":"1999","unstructured":"Bennett MW, O\u2019Connell J, O\u2019Sullivan GC et al (1999) Expression of fas ligand by human gastric adenocarcinomas: a potential mechanism of immune escape in stomach cancer. Gut 44:156\u2013162","journal-title":"Gut"},{"key":"9233_CR33","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1084\/jem.20061852","volume":"204","author":"K Lahl","year":"2007","unstructured":"Lahl K, Loddenkemper C, Drouin C et al (2007) Selective depletion of Foxp3+ regulatory T cells induces a scurfy-like disease. J Exp Med 204:57\u201363","journal-title":"J Exp Med"},{"key":"9233_CR34","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.4049\/jimmunol.160.3.1212","volume":"160","author":"E Suri-Payer","year":"1998","unstructured":"Suri-Payer E, Amae AZ, Thornton AM et al (1998) CD4+ CD25+ T cells inhibit both the induction and effector function of autoreactive T cells and represent a unique lineage of immunoregulatory cells. J Immunol 160:1212\u20131218","journal-title":"J Immunol"},{"key":"9233_CR35","doi-asserted-by":"crossref","first-page":"4272","DOI":"10.4049\/jimmunol.168.9.4272","volume":"168","author":"EY Woo","year":"2002","unstructured":"Woo EY, Yeh H, Chu CS et al (2002) Cutting edge: regulatory T cells from lung cancer patients directly inhibit autologous T cell proliferation. J Immunol 168:4272\u20134276","journal-title":"J Immunol"},{"key":"9233_CR36","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1084\/jem.194.6.823","volume":"194","author":"RPM Sutmuller","year":"2001","unstructured":"Sutmuller RPM, van Duivenvoorde LM, van Elsas A et al (2001) Synergism of cytotoxic T lymphocyte-associated antigen 4 blockade and depletion of CD25+ regulatory T cells in antitumor therapy reveals alternative pathways for suppression of autoreactive cytotoxic T lymphocyte responses. J Exp Med 194:823\u2013832","journal-title":"J Exp Med"},{"key":"9233_CR37","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S1074-7613(02)00279-0","volume":"16","author":"EA Green","year":"2002","unstructured":"Green EA, Choi Y, Flavell RA (2002) Pancreatic lymph node-derived CD4+ CD25+ T reg cells: highly potent regulators of diabetes that require TRANCE-RANK signals. Immunity 16:183\u2013191","journal-title":"Immunity"},{"key":"9233_CR38","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1038\/labinvest.3700540","volume":"87","author":"M Cao","year":"2007","unstructured":"Cao M, Cabrera R, Xu Y et al (2007) Hepatocellular carcinoma cell supernatants increase expansion and function of CD4+ CD25+ regulatory T cells. Lab Invest 87:582\u2013590","journal-title":"Lab Invest"},{"key":"9233_CR39","doi-asserted-by":"crossref","first-page":"2866","DOI":"10.1002\/cncr.22282","volume":"107","author":"RP Petersen","year":"2006","unstructured":"Petersen RP, Campa MJ, Sperlazza J et al (2006) Tumor infiltrating foxp3+ regulatory T cells are associated with recurrence in pathologic stage I NSCLC patients. Cancer 107:2866\u20132872","journal-title":"Cancer"},{"key":"9233_CR40","doi-asserted-by":"crossref","first-page":"8344","DOI":"10.1158\/0008-5472.CAN-06-3304","volume":"67","author":"S Hinz","year":"2007","unstructured":"Hinz S, Pagerols-Raluy L, Oberg HH et al (2007) Foxp3 expression in pancreatic carcinoma cells as a novel mechanism of immune evasion in cancer. Cancer Res 67:8344\u20138350","journal-title":"Cancer Res"},{"key":"9233_CR41","doi-asserted-by":"crossref","first-page":"2883","DOI":"10.4049\/jimmunol.178.5.2883","volume":"178","author":"VC Liu","year":"2007","unstructured":"Liu VC, Wong LY, Jang T et al (2007) Tumor evasion of the immune system by converting CD4+ CD25 T cells into CD4+ CD25+ T regulatory cells: role of tumor-derived TGF-\u03b2. J Immunol 178:2883\u20132892","journal-title":"J Immunol"},{"key":"9233_CR42","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1158\/1078-0432.CCR-06-2139","volume":"13","author":"SA Siddiqui","year":"2007","unstructured":"Siddiqui SA, Frigola X, Bonne-Annee S et al (2007) Tumor-infiltrating Foxp3-CD4+ CD25+ T cells predict poor survival in renal cell carcinoma. Clin Can Res 13:2075\u20132081","journal-title":"Clin Can Res"},{"key":"9233_CR43","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1182\/blood-2005-12-4827","volume":"108","author":"GH Cornish","year":"2006","unstructured":"Cornish GH, Sinclair LV, Cantrell DA (2006) Differential regulation of T-cell growth by IL-2 and IL-15. Blood 108:600\u2013608","journal-title":"Blood"},{"key":"9233_CR44","first-page":"5248","volume":"58","author":"CR Boland","year":"1998","unstructured":"Boland CR, Thibodeau SN, Hamilton SR et al (1998) A National Cancer Institute workshop on microsatellite instability for cancer detection and familial predisposistion: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res 58:5248\u20135257","journal-title":"Cancer Res"},{"key":"9233_CR45","first-page":"1713","volume":"58","author":"SN Thibodeau","year":"1998","unstructured":"Thibodeau SN, French AJ, Cunningham JM (1998) Microsatellite instability in colorectal cancer: different mutator phenotypes and the principal involvement of hMLH1. Cancer Res 58:1713\u20131718","journal-title":"Cancer Res"},{"key":"9233_CR46","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1097\/00000478-200311000-00002","volume":"27","author":"J Shia","year":"2003","unstructured":"Shia J, Ellis NA, Paty PB et al (2003) Value of histopathology in predicting microsatellite instability in hereditary nonpolyposis colorectal cancer and sporadic colorectal cancer. Am J Surg Pathol 27:1407\u20131417","journal-title":"Am J Surg Pathol"},{"key":"9233_CR47","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3233\/CBM-2006-21-205","volume":"2","author":"I Fridrichova","year":"2006","unstructured":"Fridrichova I (2006) New aspects in molecular diagnosis of Lynch syndrome (HNPCC). Cancer Biomark 2:37\u201349","journal-title":"Cancer Biomark"},{"key":"9233_CR48","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.canlet.2004.09.051","volume":"8","author":"F Baudi","year":"2005","unstructured":"Baudi F, Fersini G, Lavecchia A et al (2005) A novel missense germline mutation in exon 2 of the hMSK2 gene in a HNPCC family from Southern Italy. Cancer Lett 8:285\u2013291","journal-title":"Cancer Lett"},{"key":"9233_CR49","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1016\/0306-9877(81)90063-3","volume":"7","author":"HT Lynch","year":"1981","unstructured":"Lynch HT, Albano W, Recabaren J et al (1981) Prolonged survival as a component of hereditary breast and nonpolyposis colon cancer. Med Hypotheses 7:1201\u20131209","journal-title":"Med Hypotheses"},{"key":"9233_CR50","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1002\/1097-0142(19820715)50:2<360::AID-CNCR2820500233>3.0.CO;2-4","volume":"50","author":"WA Albano","year":"1982","unstructured":"Albano WA, Recabaren JA, Lynch HT et al (1982) Natural history of hereditary cancer of the breast and colon. Cancer 50:360\u2013363","journal-title":"Cancer"},{"key":"9233_CR51","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1002\/(SICI)1097-0142(19980715)83:2<259::AID-CNCR9>3.0.CO;2-L","volume":"83","author":"P Watson","year":"1998","unstructured":"Watson P, Lin K, Rodriguez-Bigas MA et al (1998) Colorectal carcinoma survival among hereditary nonpolyposis colorectal cancer family members. Cancer 83:259\u2013266","journal-title":"Cancer"},{"key":"9233_CR52","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1053\/gast.1996.v110.pm8608876","volume":"110","author":"R Sankila","year":"1996","unstructured":"Sankila R, Aaltonen LA, Jarvinen HJ, Mecklin JP (1996) Better survival rates in patients with MLH-1 associated hereditary colorectal cancer. Gastroenterology 110:682\u2013687","journal-title":"Gastroenterology"},{"key":"9233_CR53","first-page":"3851","volume":"50","author":"PL Ward","year":"1990","unstructured":"Ward PL, Koeppen HK, Hurteau T et al (1990) Major histocompatibility complex class I and unique antigen expression by murine tumors that escaped from CD8+ T-cell-dependent surveillance. Cancer Res 50:3851\u20133858","journal-title":"Cancer Res"},{"key":"9233_CR54","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1155\/2004\/197484","volume":"20","author":"JR Jass","year":"2004","unstructured":"Jass JR (2004) Role of the pathologist in the diagnosis of hereditary non-polyposis colorectal cancer. Dis Markers 20:215\u2013224","journal-title":"Dis Markers"},{"key":"9233_CR55","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1002\/path.1406","volume":"201","author":"JM Michael-Robinson","year":"2003","unstructured":"Michael-Robinson JM, Pandeya N, Cummings MC et al (2003) Fas ligand and tumour counter-attack in colorectal cancer stratified according to microsatellite instability status. J Pathol 201:46\u201354","journal-title":"J Pathol"},{"key":"9233_CR56","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1016\/S0002-9440(10)65436-3","volume":"154","author":"R Dolcetti","year":"1999","unstructured":"Dolcetti R, Viel A, Doglioni C et al (1999) High prevalence of activated intraepithelial cytotoxic T lymphocytes and increased neoplastic cell apoptosis in colorectal carcinomas with microsatellite instability. Am J Pathol 154:1805\u20131813","journal-title":"Am J Pathol"},{"key":"9233_CR57","doi-asserted-by":"crossref","first-page":"2654","DOI":"10.1056\/NEJMoa051424","volume":"353","author":"F Pag\u00e8s","year":"2005","unstructured":"Pag\u00e8s F, Berger A, Camus M et al (2005) Effector memory T cells, early metastasis, and survival in colorectal cancer. N Eng J Med 353:2654\u20132666","journal-title":"N Eng J Med"},{"key":"9233_CR58","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1128\/CDLI.6.4.457-463.1999","volume":"6","author":"J O\u2019Connell","year":"1999","unstructured":"O\u2019Connell J, Bennett MW, O\u2019Sullivan GC et al (1999) Expression of fas (CD95\/APO-1) ligand by human breast cancers: significance for tumor immune privilege. Clin Diag Lab Immunol 6:457\u2013463","journal-title":"Clin Diag Lab Immunol"},{"key":"9233_CR59","doi-asserted-by":"crossref","first-page":"5583","DOI":"10.4049\/jimmunol.167.10.5583","volume":"167","author":"M Saio","year":"2001","unstructured":"Saio M, Radoja S, Marino M, Frey AB (2001) Tumor-infiltrating macrophages induce apoptosis in activated CD8+ T cells by a mechanism requiring cell contact and mediated by both the cell-associated form of TNF and nitric oxide. J Immunol 167:5583\u20135593","journal-title":"J Immunol"},{"key":"9233_CR60","doi-asserted-by":"crossref","first-page":"7901","DOI":"10.1158\/1078-0432.CCR-05-1346","volume":"11","author":"JW Kim","year":"2005","unstructured":"Kim JW, Ferris RL, Whiteside TL (2005) Chemokine C receptor 7 expression and protection of circulating CD8+ T lymphocytes from apoptosis. Clin Can Res 11:7901\u20137910","journal-title":"Clin Can Res"},{"key":"9233_CR61","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.lungcan.2004.07.046","volume":"47","author":"H Prado-Garcia","year":"2005","unstructured":"Prado-Garcia H, Aguilar-Cazares D, Flores-Vergara H et al (2005) Effector, memory and naive CD8+ T cells in peripheral blood and pleural effusion from lung adenocarcinoma patients. Lung Can 47:361\u2013371","journal-title":"Lung Can"},{"key":"9233_CR62","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1054\/bjoc.2000.1113","volume":"82","author":"T Kanai","year":"2000","unstructured":"Kanai T, Watanabe M, Hayashi A et al (2000) Regulatory effect of interleukin-4 and interleukin-13 on colon cancer cell adhesion. Br J Cancer 82:1717\u20131723","journal-title":"Br J Cancer"},{"key":"9233_CR63","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.4049\/jimmunol.158.4.1591","volume":"158","author":"E Riedl","year":"1997","unstructured":"Riedl E, Strobl H, Majdic O, Knapp W (1997) TGF-\u03b21 promotes in vitro generation of dendritic cells by protecting progenitor cells from apoptosis. J Immunol 158:1591\u20131597","journal-title":"J Immunol"},{"key":"9233_CR64","doi-asserted-by":"crossref","first-page":"3329","DOI":"10.1073\/pnas.91.8.3329","volume":"91","author":"I Tamm","year":"1994","unstructured":"Tamm I, Kikutami T, Cardinale I, Krueger JG (1994) Cell-adhesion-disrupting action of interleukin-6 in human ductal breast carcinoma cells. Proc Nat Acad Sci USA 91:3329\u20133333","journal-title":"Proc Nat Acad Sci USA"},{"key":"9233_CR65","doi-asserted-by":"crossref","first-page":"4338","DOI":"10.1073\/pnas.91.10.4338","volume":"91","author":"I Tamm","year":"1994","unstructured":"Tamm I, Cardinale I, Kikutami T, Krueger JG (1994) E-cadherin distribution in interleukin 6-induced cell-cell separation of ductal breast carcinoma cells. Proc Nat Acad Sci USA 91:4338\u20134342","journal-title":"Proc Nat Acad Sci USA"},{"key":"9233_CR66","first-page":"429","volume":"23","author":"MG Catalano","year":"2007","unstructured":"Catalano MG, Fortunati N, Arena K et al (2007) Selective up-regulation of tumor necrosis factor receptor I in tumor-bearing rats with cancer-related cachexia. Int J Oncol 23:429\u2013436","journal-title":"Int J Oncol"},{"key":"9233_CR67","first-page":"581","volume":"18","author":"S Suzuki","year":"2001","unstructured":"Suzuki S, Mita S, Kamohara H et al (2001) IL-6 and IFN-gamma regulation of IL-10 production by human colon carcinoma cells. Int J Oncol 18:581\u2013586","journal-title":"Int J Oncol"},{"key":"9233_CR68","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.clim.2007.02.005","volume":"123","author":"J Huang","year":"2007","unstructured":"Huang J, Wang Y, Guo J et al (2007) Radiation-induced apoptosis along with local and systemic cytokine elaboration is associated with DC plus radiotherapy-mediated renal cell tumor regression. Clin Immunol 123:298\u2013310","journal-title":"Clin Immunol"},{"key":"9233_CR69","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1023\/B:FAME.0000039849.86008.b7","volume":"3","author":"JR Jass","year":"2004","unstructured":"Jass JR (2004) HNPCC and sporadic MSI-H colorectal cancer: a review of morphologic similarities and differences. Fam Cancer 3:93\u2013100","journal-title":"Fam Cancer"},{"key":"9233_CR70","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/0090-1229(89)90223-7","volume":"50","author":"EC Ebert","year":"1989","unstructured":"Ebert EC, Brolin RE, Roberts AI (1989) Characterization of activated lymphocytes in colon cancer. Clin Immunol Immunopath 50:72\u201381","journal-title":"Clin Immunol Immunopath"},{"key":"9233_CR71","doi-asserted-by":"crossref","first-page":"4969","DOI":"10.4049\/jimmunol.179.8.4969","volume":"179","author":"N Chaput","year":"2007","unstructured":"Chaput N, Darrasse-Jeze G, Bergot A-S et al (2007) Regulatory T cells prevent CD8 T cell maturation by inhibiting CD4 Th cells at tumor sites. J Immunol 179:4969\u20134978","journal-title":"J Immunol"},{"key":"9233_CR72","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/S0959-8049(99)00033-7","volume":"35","author":"ACP Diederichsen","year":"1999","unstructured":"Diederichsen ACP, Zeuthen J, Christensen PB, Kristensen T (1999) Characterisation of tumour infiltrating lymphocytes and correlations with immunological surface molecules in colorectal cancer. Eur J Can 35:721\u2013726","journal-title":"Eur J Can"},{"key":"9233_CR73","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1158\/0008-5472.CAN-04-3232","volume":"65","author":"LA Ormandy","year":"2005","unstructured":"Ormandy LA, Hillemann T, Wedemeyer H et al (2005) Increased populations of regulatory T cells in peripheral blood of patients with hepatocellular carcinoma. Cancer Res 65:2457\u20132464","journal-title":"Cancer Res"},{"key":"9233_CR74","first-page":"1269","volume":"14","author":"R Okita","year":"2005","unstructured":"Okita R, Saeki T, Takashima S et al (2005) CD4+ CD25+ regulatory T cells in the peripheral blood of patients with breast cancer and non-small cell lung cancer. Oncol Rep 14:1269\u20131273","journal-title":"Oncol Rep"},{"key":"9233_CR75","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1007\/s00262-005-0092-8","volume":"55","author":"K Kono","year":"2006","unstructured":"Kono K, Kawaida H, Takahashi A et al (2006) CD4(+) CD25(high) regulatory T cells increase with tumor stage in patients with gastric and esophageal cancers. Cancer Immunol Immunother 55:1064\u20131071","journal-title":"Cancer Immunol Immunother"},{"key":"9233_CR76","first-page":"4404","volume":"9","author":"F Ichihara","year":"2003","unstructured":"Ichihara F, Kono K, Takahashi A et al (2003) Increased populations of regulatory T cells in peripheral blood and tumor-infiltrating lymphocytes in patients with gastric and esophageal cancers. Clin Can Res 9:4404\u20134408","journal-title":"Clin Can Res"},{"key":"9233_CR77","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/1479-5876-4-52","volume":"4","author":"C Loddenkemper","year":"2006","unstructured":"Loddenkemper C, Schernus M, Noutsias M et al (2006) In situ analysis of FOXP3+ regulatory T cells in human colorectal cancer. J Translation Med 4:52\u201359","journal-title":"J Translation Med"},{"key":"9233_CR78","first-page":"6046","volume":"61","author":"Y Mori","year":"2001","unstructured":"Mori Y, Yin J, Rashid A et al (2001) Instabilotyping: comprehensive identification of frameshift mutations by coding region microsatellite instability. Can Res 61:6046\u20136049","journal-title":"Can Res"},{"key":"9233_CR79","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1002\/ijc.1298","volume":"93","author":"M Linnebacher","year":"2001","unstructured":"Linnebacher M, Gerbert J, Rudy W et al (2001) Frameshift peptide-derived T-cell epitopes: a source of novel tumor-specific antigens. Int J Cancer 93:6\u201311","journal-title":"Int J Cancer"},{"key":"9233_CR80","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1053\/j.gastro.2008.01.015","volume":"134","author":"Y Schwitalle","year":"2008","unstructured":"Schwitalle Y, Kloor M, Eiermann S et al (2008) Immune responses against frameshift-induced neopeptides in HNPCC patients and healthy HNPCC mutation carriers. Gastroenterology 134:988\u2013997","journal-title":"Gastroenterology"},{"key":"9233_CR81","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1002\/ijc.22691","volume":"121","author":"M Kloor","year":"2007","unstructured":"Kloor M, Michel S, Buckowitz B et al (2007) (2007) Beta2-microglobulin mutations in microsatellite unstable colorectal tumors. Int J Cancer 121:454\u2013458","journal-title":"Int J Cancer"},{"key":"9233_CR82","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1016\/S0960-9822(02)70795-1","volume":"6","author":"DC Bicknell","year":"1996","unstructured":"Bicknell DC, Kaklamanis L, Hampson R et al (1996) Selection for \u03b22 microglobulin mutation in mismatch repair-defective colorectal carcinomas. Curr Biol 6:1695\u20131697","journal-title":"Curr Biol"}],"container-title":["Familial Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10689-009-9233-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10689-009-9233-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10689-009-9233-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,23]],"date-time":"2023-05-23T17:56:21Z","timestamp":1684864581000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10689-009-9233-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,1,23]]},"references-count":82,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,9]]}},"alternative-id":["9233"],"URL":"https:\/\/doi.org\/10.1007\/s10689-009-9233-0","relation":{},"ISSN":["1389-9600","1573-7292"],"issn-type":[{"value":"1389-9600","type":"print"},{"value":"1573-7292","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,1,23]]}}}